Hydralazine Hydrochloride Tablet
Product Images NDC 70518-4007

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 70518-4007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a description of a medication called "hydrALAZINE HCI". It is in the form of tablets and each tablet contains 50 mg of the medication. The package contains 30 tablets. The medication is manufactured by Avet Pharmaceuticals Inc. located in East Brunswick, NJ 08816. The medication should be kept out of the reach of children. The package includes directions for use, which can be found in the package insert. The medication should be stored at a temperature between 20-25°C (58-77°F), with excursions permitted to 15.30°C (59-86°F) [as per USP]. The medication has been repackaged by RemedyRepack Inc., located in Indiana, PA 15701.*

FDA Label Image

Chemical-structure (Chemical Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.